SJ Berwin has won the lead role on a French-American pharma deal, strengthening its relationship with French drug company NicOx.

The City law firm won the mandate to advise NYSE Euronext Paris-listed NicOx as it bought back rights to develop and market an innovative eye disease drug from US pharma giant Pfizer.